// App-Quantinova.ai

556P : INTEGRIN BETA-3 GENETIC VARIANTS PREDICT THE RISK OF THROMBO-EMBOLIC EVENTS IN PATIENTS WITH COLORECTAL CANCER

Researchers

Presenter

  • G. Prager

Principal Investigators

  • A. Schuler

  • C. Pausz

  • D. Bianconi

  • H. Lenz

  • C. Ay

  • I. Pabinger

  • C. Zielinski

Medical Centers

  • Department of Medicine I, Medical University of Vienna, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved